Original Case: 8:17-cv-01551

Ninth Circuit U.S. Court of Appeals
Case #: 0:19-cv-55999
Typecivil / private
Nature of Suit890 Other Statutes - Other Statutory Actions
Case Filed:Aug 27, 2019
Terminated:Oct 03, 2019
Last checked: Saturday Oct 05, 2019 1:39 AM PDT
Defendant - Appellant
IMPRIMIS PHARMACEUTICALS, INC.
Represented By
Daniel L. Rasmussen
Payne & Fears LLP
contact info
David Alexander Grant
Payne & Fears LLP
contact info
Keith J. Wesley
Browne George Ross LLP
contact info
Carl Alan Roth
Browne George Ross LLP
contact info
Plaintiff - Appellee
ALLERGAN USA, INC.
Represented By
Joseph Nicholas Akrotirianakis
King and Spalding LLP
contact info
Jeffrey S. Bucholtz
King & Spalding LLP
contact info


Docket last updated: 10/05/2019 1:36 AM PDT
Tuesday, August 27, 2019
1 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Mediation Questionnaire due on 09/03/2019. Transcript ordered by 09/26/2019. Transcript due 10/25/2019. Appellant Imprimis Pharmaceuticals, Inc. opening brief due 12/05/2019. Appellee Allergan USA, Inc. answering brief due 01/06/2020. Appellant's optional reply brief is due 21 days after service of the answering brief. [11412028] (RT) [Entered: 08/27/2019 01:16 PM]
Related: [-]
Att: 1 3 pgs Docketing Letter
Att: 2 1 pgs Mediation Letter
Att: 3 2 pgs Mediation Questionnaire
Att: 4 22 pgs Case Opening Packet